Hu3S193

· Recepta Biopharma

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hu3S193, covering 2013-11-26 to 2016-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]